SynthesisAlimentary pharmacology & therapeutics2025
Meta-Analysis: Intravenous Versus Subcutaneous Infliximab in Inflammatory Bowel Disease.
John David Chetwood et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papertrialcites it